Wed, Nov 25, 2020
The 52 Week Low is $113.43 set on Fri, Mar 20, 2020.
The 52 Week High is $224.24 set on Mon, Nov 9, 2020.
The All-Time High is $224.24 set on Mon, Nov 9, 2020.
Earnings Per Share
Price To Earnings Ratio
Dividend Payment Date
ResMed trades on the NYSE. RMD's market cap is 29.9 Billion.
ResMed is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns 65% of revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.